Adage Capital Management, L.P. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 09:06 am Purchase | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 4,392,696 9.580% | 1,070,550 (+32.22%) | Filing |
| 2024-11-12 09:33 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,322,146 8.550% | 3,322,146 (New Position) | Filing |